Citation Impact
Citing Papers
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Videolaparoscopic cholecystectomy induces a hemostasis activation of lower grade than does open surgery
2000
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Collagen‐platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament
2006
Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns
2018
Toward the quiescent coronary plaque
1993
Perioperative Management of Antithrombotic Therapy
2012 Standout
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
2009
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis
1992
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
2016
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds
2017
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Venous thromboembolism (VTE) in Europe
2007 Standout
Prevention of Venous Thromboembolism
2004 Standout
Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
2016 Standout
Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance
2012
Circadian Variation of Fibrinolytic Activity in Blood
1991
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model
2018
Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention
2007
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Impaired T-cell differentiation in diabetic foot ulceration
2016
Prevention of Venous Thromboembolism
2008 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Burn injury
2020 Standout
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Coagulation and Fibrinolysis during Laparoscopic Cholecystectomy
1999
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Diurnal Rhythm in Anticoagulant Effect of Heparin during a Low Dose Constant Rate Infusion
1992
Different doses of low-level laser irradiation modulate thein vitroresponse of osteoblast-like cells
2014
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Diabetes and Cancer
2010 Standout
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
1990
Photobiomodulation: lasers vs. light emitting diodes?
2018 Standout
Platelet-Rich Plasma
2009 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
1993
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?
2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
1991
Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study
1995
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Treatment related changes in antifibrinolytic activity in patients with polycythemia vera
2010
Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma
1990
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Molecular Bases of the Acute Coronary Syndromes
1995 Standout
Works of Danuta Rość being referenced
A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus
2014
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
2015
Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: No evidence for clinical benefit of heparinization during the initial phase of treatment
1989
Diurnal variation in platelet inhibition by clopidogrel
2011
The influence of laparoscopic cholecystectomy on perioperative blood clotting and fibrinolysis
1997
Circadian Fluctuations of Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma of Patients with Unstable Coronary Artery Disease and Acute Myocardial Infarction
1988
Endothelial progenitor cells in diabetic foot syndrome.
2013
[Plasminogenesis in blood of patients with chronic myeloproliferative syndromes].
2006
Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
2002
Phototherapy with low-level laser influences the proliferation of endothelial cells and vascular endothelial growth factor and transforming growth factor-beta secretion.
2013
[Plasminogen activator inhibitor type 1 (PAI-1) in blood and tissue extracts of patients with non-small cell lung cancer].
2004